Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease

Paula L. McClean, Christian Hölscher

Research output: Contribution to journalArticlepeer-review

90 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Lixisenatide, a drug developed to treat type 2 diabetes, shows neuroprotective effects in a mouse model of Alzheimer's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences